296 related articles for article (PubMed ID: 15879806)
21. Nifedipine versus tamsulosin for the management of lower ureteral stones.
Porpiglia F; Ghignone G; Fiori C; Fontana D; Scarpa RM
J Urol; 2004 Aug; 172(2):568-71. PubMed ID: 15247732
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones.
Sun X; He L; Ge W; Lv J
J Urol; 2009 Apr; 181(4):1716-20. PubMed ID: 19233432
[TBL] [Abstract][Full Text] [Related]
23. A second cycle of tamsulosin in patients with distal ureteric stones: a prospective randomized trial.
Porpiglia F; Fiori C; Ghignone G; Vaccino D; Billia M; Morra I; Ragni F; Scarpa RM
BJU Int; 2009 Jun; 103(12):1700-3. PubMed ID: 19159408
[TBL] [Abstract][Full Text] [Related]
24. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy.
Resim S; Ekerbicer HC; Ciftci A
Urology; 2005 Nov; 66(5):945-8. PubMed ID: 16286100
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of medical expulsive treatment with doxazosin in pediatric patients.
Erturhan S; Bayrak O; Sarica K; Seckiner I; Baturu M; Sen H
Urology; 2013 Mar; 81(3):640-3. PubMed ID: 23343614
[TBL] [Abstract][Full Text] [Related]
26. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi?
Bhagat SK; Chacko NK; Kekre NS; Gopalakrishnan G; Antonisamy B; Devasia A
J Urol; 2007 Jun; 177(6):2185-8. PubMed ID: 17509314
[TBL] [Abstract][Full Text] [Related]
27. Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones.
Çelik S; Akdeniz F; Afsar Yildirim M; Bozkurt O; Gursoy Bulut M; Hacihasanoglu ML; Demir O
Arch Ital Urol Androl; 2018 Jun; 90(2):117-122. PubMed ID: 29974727
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of alpha-blockers for the treatment of ureteral stones.
Parsons JK; Hergan LA; Sakamoto K; Lakin C
J Urol; 2007 Mar; 177(3):983-7; discussion 987. PubMed ID: 17296392
[TBL] [Abstract][Full Text] [Related]
29. Doxazosin for the management of distal-ureteral stones.
Liatsikos EN; Katsakiori PF; Assimakopoulos K; Voudoukis T; Kallidonis P; Constantinides C; Athanasopoulos A; Stolzenburg JU; Perimenis P
J Endourol; 2007 May; 21(5):538-41. PubMed ID: 17523910
[TBL] [Abstract][Full Text] [Related]
30. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study.
Pedro RN; Hinck B; Hendlin K; Feia K; Canales BK; Monga M
J Urol; 2008 Jun; 179(6):2244-7; discussion 2247. PubMed ID: 18423747
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of tamsulosin with extracorporeal shock wave lithotripsy for passage of renal and ureteral calculi.
Losek RL; Mauro LS
Ann Pharmacother; 2008 May; 42(5):692-7. PubMed ID: 18413683
[TBL] [Abstract][Full Text] [Related]
32. Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy.
Ohgaki K; Horiuchi K; Hikima N; Kondo Y
Scand J Urol Nephrol; 2010 Dec; 44(6):420-4. PubMed ID: 20604720
[TBL] [Abstract][Full Text] [Related]
33. Effect of alpha1-adrenergic antagonists on lower ureteral stones with extracorporeal shock wave lithotripsy.
Wang H; Liu K; Ji Z; Li H
Asian J Surg; 2010 Jan; 33(1):37-41. PubMed ID: 20497881
[TBL] [Abstract][Full Text] [Related]
34. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial.
Sur RL; Shore N; L'Esperance J; Knudsen B; Gupta M; Olsen S; Shah O
Eur Urol; 2015 May; 67(5):959-64. PubMed ID: 25465978
[TBL] [Abstract][Full Text] [Related]
35. Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone.
Kobayashi M; Naya Y; Kino M; Awa Y; Nagata M; Suzuki H; Yamaguchi K; Nozumi K; Ichikawa T
Int J Urol; 2008 Jun; 15(6):495-8. PubMed ID: 18422579
[TBL] [Abstract][Full Text] [Related]
36. A comparison of efficacy of doxazosin 4 and 8 mg in medical expulsive therapy of distal ureteral stones: a prospective randomized clinical trial.
Sen H; Erturhan S; Sadioglu E; Bayrak O; Seckiner İ
Urolithiasis; 2017 Oct; 45(5):461-464. PubMed ID: 27717996
[TBL] [Abstract][Full Text] [Related]
37. Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience.
De Sio M; Autorino R; Di Lorenzo G; Damiano R; Giordano D; Cosentino L; Pane U; Di Giacomo F; Mordente S; D'Armiento M
J Endourol; 2006 Jan; 20(1):12-6. PubMed ID: 16426124
[TBL] [Abstract][Full Text] [Related]
38. Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.
Zhou SG; Lu JL; Hui JH
World J Urol; 2011 Dec; 29(6):767-71. PubMed ID: 21845472
[TBL] [Abstract][Full Text] [Related]
39. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
Tsai YS; Lan SK; Ou JH; Tzai TS
Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones.
Dellabella M; Milanese G; Muzzonigro G
J Urol; 2003 Dec; 170(6 Pt 1):2202-5. PubMed ID: 14634379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
